Gilead Sciences, Inc.
GILD
Market Cap$142.47B
Volume172.35K
Revenue$28.86B
Gross Profits$22.67B
Employees17600
About
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truv...